LPL Financial
BCLI

LPL Financial’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

LPL Financial’s Portfolio BCLI Stock Details BCLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,698
Closed -$12K – 5819
2025
Q2 		$12K Buy
+10,698
New +$12K ﹤0.01% 5514
2024
Q3 		– Sell
-670
Closed -$3.4K – 5178
2024
Q2 		$3.4K Buy
+670
New +$5.02K ﹤0.01% 5004
2023
Q4 		– Sell
-2,763
Closed -$8.29K – 4805
2023
Q3 		$8.29K Sell
2,763
-6
-0.2% -$136 ﹤0.01% 4652
2023
Q2 		$85.6K Buy
+2,769
New +$115K ﹤0.01% 4350
2016
Q2 		– Sell
-667
Closed -$27K – 2649
2016
Q1 		$27K Hold
667
– – ﹤0.01% 3041
2015
Q4 		$31K Buy
+667
New +$27.5K ﹤0.01% 3086

Other funds holding BCLI

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
BSB
Bangor Savings Bank Bangor, Maine $1.36B AUM 19.29% 1-Year Est. Return
VWA
VSM Wealth Advisory Hunt Valley, Maryland $335M AUM 16.18% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
DJSG
D.J. St. Germain Springfield, Massachusetts $2.53B AUM 17.43% 1-Year Est. Return

LPL Financial's BCLI Position: Q3 2025 in Review

LPL Financial sold out of BRAINSTORM CELL THERAPUTC (BCLI) in Q3 2025, closing a stake of 10,698 shares — an estimated $12K sold.

LPL Financial first reported a position in BCLI in Q4 2015 and held it in 6 quarters. The position peaked at $85.6K in Q2 2023. 5 funds tracked by Wall St. Rank hold BCLI as of Q3 2025.

  • LPL Financial reported no remaining BRAINSTORM CELL THERAPUTC position as of Q3 2025 after selling out during the quarter.
  • LPL Financial sold 10,698 BRAINSTORM CELL THERAPUTC shares in Q3 2025, an estimated $12K.
  • LPL Financial first reported a position in BRAINSTORM CELL THERAPUTC in Q4 2015 and held it in 6 quarters.
  • LPL Financial's BRAINSTORM CELL THERAPUTC position peaked at $85.6K in Q2 2023.
  • 5 funds tracked by Wall St. Rank held BRAINSTORM CELL THERAPUTC as of Q3 2025.

Based on LPL Financial's 13F filing for Q3 2025, filed 12 Nov 2025.